
Semaglutide Approved for Liver Condition Treatment
The story in brief
Semaglutide, a weight loss drug, has been approved to treat liver conditions affecting one in three Indians. The drug improves insulin sensitivity and has been linked to reduced liver cell injury and scarring. Dr. Akhil Deshmukh, a Consultant in Hepatology and Liver Transplant, said the approval is likely to change the management approach for Metabolic Dysfunction-Associated Steatohepatitis (MASH).